Efficacy and safety of baricitinib in patients with severe COVID-19: A systematic review and meta-analysis
Description
CONCLUSION: Baricitinib reduces mortality and mechanical ventilation requirements in patients with severe COVID-19. Therefore, we developed a comprehensive understanding of the role of baricitinib in patients with severe COVID-19.
